Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors

摘要: The invention relates to a method of treatment indications which can be positively influenced by inhibition AT1 mediated effects with maintenance AT2 receptor Angiotensin II and ACE inhibition, thus also increasing bradykinin effects, e.g. reduce the incidence stroke, acute myocardial infarction or cardiovascular death, associated increase receptors in sub-epithelial area epithelia, comprising co-administration effective amounts an antagonist inhibitor, pharmaceutical compositions containing together inhibitor use for manufacture corresponding compositions.